Medinotec (MDNC) Change in Working Capital (2023 - 2024)

Medinotec (MDNC) posted Change in Working Capital of $25203.0 for Q4 2024, down 52.16% on a QoQ basis from $52683.0 in Q4 2023, and down 52.16% year-over-year from $52683.0 in Q4 2023.

Medinotec (MDNC) Change in Working Capital (2023 - 2024) Analysis & Trends

Medinotec's Change in Working Capital history runs 2 years deep, the most recent figure standing at $25203.0 for Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Working Capital (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -128.78 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Medinotec 58.78 Mn 58.19 Mn 1.31 Mn -

Historic Data

Download Data
DateValue
Nov 30, 2024 25,203.00
Nov 30, 2024 25,203.00
Nov 30, 2023 52,683.00
Nov 30, 2023 52,683.00